VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $255,050,828 | +12.1% | 9,477,920 | +25.4% | 0.03% | +12.0% |
Q2 2023 | $227,547,201 | -40.0% | 7,557,197 | -35.5% | 0.02% | -45.7% |
Q1 2023 | $378,982,258 | +165885.9% | 11,715,047 | +47.1% | 0.05% | +53.3% |
Q4 2022 | $228,322 | -99.9% | 7,966,593 | -0.3% | 0.03% | +7.1% |
Q3 2022 | $192,709,000 | +7.0% | 7,989,628 | +21.5% | 0.03% | +12.0% |
Q2 2022 | $180,089,000 | +1.4% | 6,577,362 | +42.0% | 0.02% | +19.0% |
Q1 2022 | $177,639,000 | +405.6% | 4,632,022 | +322.3% | 0.02% | +425.0% |
Q4 2021 | $35,135,000 | -44.4% | 1,096,924 | -48.9% | 0.00% | -50.0% |
Q3 2021 | $63,226,000 | -56.2% | 2,145,498 | -49.5% | 0.01% | -52.9% |
Q2 2021 | $144,435,000 | -50.4% | 4,250,565 | -52.6% | 0.02% | -56.4% |
Q1 2021 | $291,259,000 | -51.9% | 8,961,818 | -46.7% | 0.04% | -56.2% |
Q4 2020 | $605,436,000 | +100.1% | 16,808,313 | +118.7% | 0.09% | +74.5% |
Q3 2020 | $302,512,000 | +9.3% | 7,683,842 | +1.8% | 0.05% | -3.8% |
Q2 2020 | $276,848,000 | -16.3% | 7,547,662 | -47.4% | 0.05% | -32.1% |
Q1 2020 | $330,824,000 | +139.7% | 14,358,675 | +204.7% | 0.08% | +200.0% |
Q4 2019 | $137,989,000 | +14.1% | 4,712,716 | +4.0% | 0.03% | +8.3% |
Q3 2019 | $120,978,000 | -44.7% | 4,529,282 | -47.6% | 0.02% | -44.2% |
Q2 2019 | $218,879,000 | -13.9% | 8,641,136 | -23.8% | 0.04% | -17.3% |
Q1 2019 | $254,346,000 | +173.2% | 11,344,570 | +157.0% | 0.05% | +136.4% |
Q4 2018 | $93,100,000 | +533.4% | 4,414,460 | +456.2% | 0.02% | +633.3% |
Q3 2018 | $14,698,000 | -93.5% | 793,649 | -92.1% | 0.00% | -93.5% |
Q2 2018 | $224,937,000 | +1078.1% | 10,082,319 | +1060.6% | 0.05% | +1050.0% |
Q1 2018 | $19,094,000 | -54.8% | 868,708 | -52.2% | 0.00% | -55.6% |
Q4 2017 | $42,204,000 | +67.2% | 1,815,964 | +66.6% | 0.01% | +50.0% |
Q3 2017 | $25,237,000 | +18.8% | 1,089,696 | +13.3% | 0.01% | +20.0% |
Q2 2017 | $21,239,000 | -42.2% | 961,939 | -40.3% | 0.01% | -37.5% |
Q1 2017 | $36,745,000 | +78.2% | 1,610,903 | +63.4% | 0.01% | +60.0% |
Q4 2016 | $20,624,000 | -44.3% | 985,847 | -29.6% | 0.01% | -44.4% |
Q3 2016 | $37,028,000 | -57.8% | 1,400,990 | -55.8% | 0.01% | -59.1% |
Q2 2016 | $87,705,000 | – | 3,166,245 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |